-
Models for open innovation in the pharmaceutical industry.
August 2, 2013 Editor 0
Models for open innovation in the pharmaceutical industry.
Drug Discov Today. 2013 Jul 25;
Authors: Schuhmacher A, Germann PG, Trill H, Gassmann O
Abstract
The nature of the pharmaceutical industry is such that the main driver for its growth is innovation. In view of the vast challenges that the industry has been facing for several years and, in particular, how to manage stagnating research and development (R&D) productivity, pharmaceutical companies have opened their R&D organizations to external innovation. Here, we identify and characterize four new types of open innovator, which we call ‘knowledge creator’, ‘knowledge integrator’, ‘knowledge translator’ and ‘knowledge leverager’, and which describe current open R&D models.
PMID: 23892183 [PubMed – as supplied by publisher]
HE Mahama Urges African Govts to Invest in Agric Research How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
